Value-based health care: issues for pharmaceutical companies
Michael Lampert, Ropes & Gray health care partner, discusses issues facing pharmaceutical companies with the move towards value-based health care models.
Trending Legal Topics Similar Videos
New anti-abuse provisions
Kat Saunders Gregor, Ropes & Gray tax partner and co-founder of the tax controversy group, examines the influx of new anti-abuse provisions around the world.
Enforcement of electronic health records
Joshua Levy, co-chair of Ropes & Gray’s litigation & enforcement practice, addresses an emerging trend in the electronic health records space, where a number of companies are being investigated under the False Claims Act.
SEC priorities for asset management industry
David Tittsworth, Ropes & Gray investment management counsel, examines what’s changed for the asset management industry under the Trump administration and what to expect during 2018.
Donations to patient assistance charities
Laura Hoey, Ropes & Gray litigation & enforcement partner, examines the increased enforcement of donations from drug manufacturers to patient assistance charities.
Anti-corruption & international risk developments
Alex Rene, co-chair of Ropes & Gray’s anti-corruption / international risk practice and managing partner of the firm’s Washington, D.C. office, discusses recent FCPA enforcement activity as well as international risks facing companies.
Impact of tax reform on charitable giving
Cameron Casey, Ropes & Gray private client group partner, examines the various reforms included in the Tax Cuts and Jobs Act (TCJA) and how they may affect the federal tax benefits of charitable giving.